Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China · Delayed Price · Currency is CNY 16.56
-0.39 (-2.30%)
Mar 19, 2026, 3:00 PM CST
Cisen Pharmaceutical Market Cap
Cisen Pharmaceutical has a market cap or net worth of 7.5 billion as of March 19, 2026. Its market cap has increased by 25.08% in one year.
Market Cap
7.50B
Enterprise Value
4.24B
Revenue
3.56B
Ranking
n/a
PE Ratio
15.33
Stock Price
16.56
Market Cap Chart
Since September 29, 2017, Cisen Pharmaceutical's market cap has decreased from 7.61B to 7.50B, a decrease of -1.50%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 7.50B | -4.39% |
| Dec 31, 2025 | 7.84B | 26.06% |
| Dec 31, 2024 | 6.22B | -5.76% |
| Dec 29, 2023 | 6.60B | 16.46% |
| Dec 30, 2022 | 5.67B | -5.19% |
| Dec 31, 2021 | 5.98B | -4.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Wit Dyne Health | 7.84B |
| Changchun BCHT Biotechnology Co. | 7.82B |
| Zhejiang Tianyu Pharmaceutical | 7.73B |
| Jiuzhitang | 7.69B |
| Northeast Pharmaceutical Group | 7.62B |
| Sichuan Huiyu Pharmaceutical | 7.57B |
| Dezhan Healthcare Company | 7.53B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 7.48B |